Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Series A-1 Preferred
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Deficit
Beginning balance (in shares) at Jan. 01, 2022   238,729        
Beginning balance (in shares) at Jan. 01, 2022     2,827,410      
Beginning balance at Jan. 01, 2022 $ (8,676) $ 0 $ 2 $ 45,743 $ (53,804) $ (617)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share based compensation 4     4    
Other comprehensive income (49)       (8) (41)
Net income 1,211       1,211  
Ending balance (in shares) at Apr. 02, 2022   238,729        
Ending balance (in shares) at Apr. 02, 2022     2,827,410      
Ending balance at Apr. 02, 2022 (7,510) $ 0 $ 2 45,747 (52,601) (658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Series A-1 preferred converted (in shares)   (16,141) 322,820      
Other comprehensive income 41         41
Net income 8,874       8,874  
Ending balance (in shares) at Jul. 02, 2022   222,588        
Ending balance (in shares) at Jul. 02, 2022     3,150,230      
Ending balance at Jul. 02, 2022 $ 1,405 $ 0 $ 2 45,747 (43,727) (617)
Beginning balance (in shares) at Dec. 31, 2022 222,588 222,588        
Beginning balance (in shares) at Dec. 31, 2022 2,827,410   3,150,230      
Beginning balance at Dec. 31, 2022 $ 2,307 $ 0 $ 2 45,748 (42,822) (621)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share based compensation 8     8    
Common stock issued for equity financing (in share)     361,000      
Common stock issued for equity financing 369   $ 1 368    
Series A-1 preferred converted (in shares)   (5,185) 103,707      
Series A-1 preferred converted 170     170    
Other comprehensive income 621         621
Net income 10,085       10,085  
Ending balance (in shares) at Apr. 01, 2023   217,403        
Ending balance (in shares) at Apr. 01, 2023     3,614,937      
Ending balance at Apr. 01, 2023 13,560 $ 0 $ 3 46,294 (32,737) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share based compensation 5     5    
Net income $ 123       123  
Ending balance (in shares) at Jul. 01, 2023 209,706 217,403        
Ending balance (in shares) at Jul. 01, 2023 3,768,878   3,614,937      
Ending balance at Jul. 01, 2023 $ 13,688 $ 0 $ 3 $ 46,299 $ (32,614) $ 0